Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Open-market sale Director sold 1,700 shares at $109.83 ($186,716)
  2. 4 Open-market sale Director sold 6,467 shares at an average $107.17 ($693,039)
  3. 4 Open-market sale Director sold 3,533 shares at $107.10 ($378,378)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Chief Executive Officer acquired 16,653 shares (grant or award)
  11. 4 Open-market sale Director sold 100 shares at $113.70 ($11,370)
  12. 4 Open-market sale Director sold 100 shares at $111.03 ($11,103)
  13. 4 Shares withheld for taxes SVP Clinical Controls gave up 309 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP - General Counsel gave up 277 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP - Novus Biologicals gave up 533 shares (to pay taxes)
  16. 4 Open-market sale Director sold 100 shares at $112.15 ($11,215)
  17. 4 Open-market sale Director sold 100 shares at $102.53 ($10,253)
  18. 4 Open-market sale Director sold 5,000 shares at $101.91 ($509,550)
  19. 4 Option exercise Director acquired 5,000 shares (option exercise)
  20. 4 Open-market sale Director sold 500 shares at $100.24 ($50,120)

Page 20 of 35 · 695 filings